Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, ...

Elevance Health (NYSE: ELV) Q4 2024 Earnings Call Jan 23, 2025, 8:30 a.m. ET ...

Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8. Operator: Ladies and gentlemen, thank you for ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

According to LCH Investments, over 200 hedge funds are Tiger Cubs, funds started by former employees of Tiger Management, the ...

The Fund (Class Z) underperformed its benchmark, the MSCI World Value Index, for the quarter ended December 31, 2024. Read ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Barclays raised the firm’s price target on Elevance Health (ELV) to $512 from $501 and keeps an Overweight rating on the shares post the Q4 ...